Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Liraglutide

Gut Microbiome Changes Following Liraglutide Treatment in Obese Subjects or Overweight Subjects With Co-morbidities

Novo Nordisk · Phase 3 · Status n/r · Enrollment 300

NCT04525300

ArmPopulationDoseWeeksEstimandWeight change
LiraglutideObesity or overweightn/r28n/rn/r
placeboObesity or overweightn/r28n/rn/r